Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Loaded Human IL-1RL1, Fc Tag (Cat. No. IL1-H5250) on Protein A Biosensor, can bind with Biotinylated Human IL-33, His,Avitag (Cat. No. IL3-H82H5) an affinity constant of 1.81 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Astegolimab | AMG-282; RG-6149; RO-7187807 | Phase 3 Clinical | Amgen Inc, F. Hoffmann-La Roche Ltd | Coronavirus Disease 2019 (COVID-19); Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
Recombinant humanized anti-ST2 monoclonal antibody | 9-MW1911; 9MW-1911; 9-MW-1911; 9MW1911 | Phase 2 Clinical | Mabwell (Shanghai) Bioscience Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
Melrilimab | GSK-3772847; CNTO-7160 | Phase 2 Clinical | Johnson & Johnson Innovative Medicine | Asthma | Details |
TQC-2938 | TQC2938; TQC-2938 | Phase 1 Clinical | Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group | Asthma | Details |
Astegolimab | AMG-282; RG-6149; RO-7187807 | Phase 3 Clinical | Amgen Inc, F. Hoffmann-La Roche Ltd | Coronavirus Disease 2019 (COVID-19); Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
Recombinant humanized anti-ST2 monoclonal antibody | 9-MW1911; 9MW-1911; 9-MW-1911; 9MW1911 | Phase 2 Clinical | Mabwell (Shanghai) Bioscience Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
Melrilimab | GSK-3772847; CNTO-7160 | Phase 2 Clinical | Johnson & Johnson Innovative Medicine | Asthma | Details |
TQC-2938 | TQC2938; TQC-2938 | Phase 1 Clinical | Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group | Asthma | Details |
This web search service is supported by Google Inc.